| 11267804 |
(R)-8-(1-((3-fluorophenyl)amino)ethyl)-N-(2-hydroxyethyl)-2-morpholinoquinoxaline-6-carboxamide for inhibiting phosphoinositide-3-kinase activity |
Patrick René Angibaud, Olivier Alexis Georges Querolle, Didier Jean-Claude Berthelot, Matthieu WILLOT, Lieven Meerpoel +1 more |
2022-03-08 |
$372,209,000 |
| 11130751 |
Quinoxaline and pyridopyrazine derivatives as PI3K-beta inhibitors |
Patrick René Angibaud, Olivier Alexis Georges Querolle, Didier Jean-Claude Berthelot, Matthieu WILLOT, Lieven Meerpoel +1 more |
2021-09-28 |
$293,549,000 |
| 10980725 |
Cosmetic compositions and method of treating the skin |
Cecilia BRUN, Thierry Oddos |
2021-04-20 |
$98,264,000 |
| 10894793 |
Bicyclic pyridine, pyrazine, and pyrimidine derivatives as PI3K beta inhibitors |
Didier Jean-Claude Berthelot, Laurence Anne Mevellec, Patrick René Angibaud, Sophie Coupa, Christophe Gabriel Marcel Demestre +6 more |
2021-01-19 |
$146,074,000 |
| 10526316 |
Quinoxaline and pyridopyrazine derivatives as PI3Kβ inhibitors |
Patrick René Angibaud, Olivier Alexis Georges Querolle, Didier Jean-Claude Berthelot, Matthieu WILLOT, Lieven Meerpoel +1 more |
2020-01-07 |
$77,223,000 |
| 10202387 |
Heterocyclyl linked imidazopyridazine derivatives as PI3KB inhibitors |
Laurence Anne Mevellec, Lieven Meerpoel, Sophie Coupa, Virginie Sophie Poncelet, Isabelle Noëlle Constance Pilatte +6 more |
2019-02-12 |
$117,769,000 |
| 10087187 |
Imidazopyridazine derivatives as PI3KB inhibitors |
Laurence Anne Mevellec, Lieven Meerpoel, Sophie Coupa, Virginie Sophie Poncelet, Isabelle Noëlle Constance Pilatte +6 more |
2018-10-02 |
$95,730,000 |
| 10077261 |
Imidazolin-5-one derivative useful as FASN inhibitors for the treatment of cancer |
Peter J. Connolly, Gilles Bignan, Tianbao Lu, Michael H. Parker, Donald Ludovici +3 more |
2018-09-18 |
$145,875,000 |
| 9598396 |
Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerization inhibitors |
Patrick René Angibaud, Laurence Anne Mevellec, Bruno Roux, Pierre-Henri Storck, Jorge Eduardo Vialard |
2017-03-21 |
$98,944,000 |
| 9527798 |
Cyclopropylboronic compounds, preparation process thereof and use thereof |
Peter Oosting, Emmanuel Thomas, Rukiye Pamuk, Benoit Folleas, Jean-Louis Brayer +2 more |
2016-12-27 |
|
| 9150540 |
Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as parp and tubulin polymerization inhibitors |
Patrick René Angibaud, Laurence Anne Mevellec, Bruno Roux, Pierre-Henri Storck, Jorge Eduardo Vialard |
2015-10-06 |
$37,968,000 |
| 8889866 |
Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerization inhibitors |
Patrick René Angibaud, Laurence Anne Mevellec, Bruno Roux, Pierre-Henri Storck, Jorge Eduardo Vialard |
2014-11-18 |
$85,656,000 |
| 8883837 |
Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication |
Jean-François Bonfanti, Koenraad Jozef Lodewijk Marcel Andries, Jérôme Michel Claude Fortin, Philippe Muller, Frédéric Marc Maurice Doublet +3 more |
2014-11-11 |
$67,521,000 |
| 8778966 |
Quinolinone derivatives as PARP and tank inhibitors |
Jorge Eduardo Vialard, Patrick René Angibaud, Laurence Anne Mevellec, Eddy Jean Edgard Freyne, Isabelle Noëlle Constance Pilatte +10 more |
2014-07-15 |
$40,089,000 |
| 8404683 |
Inhibitors of the interaction between MDM2 and P53 |
Jean Ferand Armand Lacrampe, Yannick Aime Eddy Ligny, Imre Christian Francis Csoka, Luc Van Hijfte, Janine Arts +5 more |
2013-03-26 |
$52,999,000 |
| 8404713 |
Quinolinone derivatives as PARP inhibitors |
Patrick René Angibaud, Laurence Françoise Bernadette Marconnet-Decrane, Jorge Eduardo Vialard, Laurence Anne Mevellec, Pierre-Henri Storck |
2013-03-26 |
$52,999,000 |
| 8377961 |
Cyclic-alkylamine derivatives as inhibitors of the interaction between MDM2 and P53 |
Jean Fernand Armand Lacrampe, Bruno Schoentjes, Alain Philippe Poncelet, Camille G. Wermuth, Bruno Giethlen +3 more |
2013-02-19 |
$42,397,000 |
| 8299256 |
Quinolinone derivatives as PARP and TANK inhibitors |
Jorge Eduardo Vialard, Patrick René Angibaud, Laurence Anne Mevellec, Eddy Jean Edgard Freyne, Isabelle Noëlle Constance Pilatte +10 more |
2012-10-30 |
|
| 8278455 |
5- or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication |
Jean-François Bonfanti, Koenraad Jozef Lodewijk Marcel Andries, Jérôme Michel Claude Fortin, Philippe Muller, Frédéric Marc Maurice Doublet +3 more |
2012-10-02 |
$65,904,000 |
| 8232298 |
Inhibitors of the interaction between MDM2 and P53 |
Jean Fernand Armand Lacrampe, Bruno Schoentjes, Delphine Yvonne Raymonde Lardeau, Alain Philippe Poncelet, Luc Van Hijfte |
2012-07-31 |
$66,960,000 |
| 8168644 |
Quinazolinone derivatives as tubulin polymerization inhibitors |
Eddy Jean Edgard Freyne, Laurence Anne Mevellec, Jorge Eduardo Vialard, Elisabeth Therese Jeanne Pasquier, Xavier Marc Bourdrez +1 more |
2012-05-01 |
$71,714,000 |
| 8088795 |
Cyclic-alkylamine derivatives as inhibitors of the interaction between MDM2 and p53 |
Jean Fernand Armand Lacrampe, Bruno Schoentjes, Alain Philippe Poncelet, Camille G. Wermuth, Bruno Giethlen +3 more |
2012-01-03 |
$122,734,000 |
| 8044073 |
Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication |
Jean-François Bonfanti, Koenraad Jozef Lodewijk Marcel Andries, Jér{hacek over (o)}me Michel Claude Fortin, Philippe Muller, Frédéric Marc Maurice Doublet +3 more |
2011-10-25 |
|
| 7943635 |
Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors |
Patrick René Angibaud, Marc Gaston Venet, Henry J. Breslin |
2011-05-17 |
$84,455,000 |
| 7834016 |
Inhibitors of the interaction between MDM2 and p53 |
Jean Fernand Armand Lacrampe, Yannick Aime Eddy Ligny, Imre Christian Francis Csoka, Luc Van Hijfte, Janine Arts +5 more |
2010-11-16 |
$38,674,000 |
